ICD Medicare Coverage Expansion Unwarranted, Insurance Group Contends
This article was originally published in The Gray Sheet
Executive Summary
America's Health Insurance Plans' efforts to dissuade CMS from expanding ICD national coverage until more conclusive evidence becomes available reflects the insurance industry's insistence on evidence-based medicine to justify expensive technologies
You may also be interested in...
ICD Benefits Roughly Equal For Ischemics, Non-Ischemics – JAMA Study
Implantable cardioverter defibrillators are associated with roughly the same relative benefit over medical therapy in both non-ischemic and ischemic cardiomyopathy patients, according to a meta-analysis by Akshay Desai, MD, Brigham and Women's Hospital, et al.
ICD Benefits Roughly Equal For Ischemics, Non-Ischemics – JAMA Study
Implantable cardioverter defibrillators are associated with roughly the same relative benefit over medical therapy in both non-ischemic and ischemic cardiomyopathy patients, according to a meta-analysis by Akshay Desai, MD, Brigham and Women's Hospital, et al.
National ICD Registry Proposal Critiqued By Manufacturers, ACC/HRS
CMS' implantable cardioverter defibrillator registry should limit its initial scope to follow-up data at the time of re-hospitalization to keep expenses manageable, according to ICD manufacturers and professional societies